Quartz Partners LLC Purchases New Position in Encompass Health Corporation $EHC

Quartz Partners LLC purchased a new stake in Encompass Health Corporation (NYSE:EHC) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 21,128 shares of the company’s stock, valued at approximately $2,136,000.

Several other large investors have also recently added to or reduced their stakes in EHC. WPG Advisers LLC increased its holdings in shares of Encompass Health by 73.3% during the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after buying an additional 137 shares in the last quarter. Persistent Asset Partners Ltd acquired a new position in shares of Encompass Health in the 2nd quarter worth approximately $36,000. Assetmark Inc. boosted its holdings in shares of Encompass Health by 89.6% in the 1st quarter. Assetmark Inc. now owns 455 shares of the company’s stock worth $44,000 after acquiring an additional 215 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after acquiring an additional 362 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Encompass Health during the 4th quarter valued at $55,000. 97.25% of the stock is owned by institutional investors.

Insider Activity at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the sale, the executive vice president owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Mark J. Tarr sold 173,148 shares of Encompass Health stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the transaction, the chief executive officer directly owned 267,814 shares in the company, valued at approximately $33,602,622.58. This represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by corporate insiders.

Encompass Health Trading Down 0.1%

NYSE EHC opened at $121.95 on Thursday. Encompass Health Corporation has a 12 month low of $92.77 and a 12 month high of $127.99. The stock has a 50-day simple moving average of $110.26 and a 200 day simple moving average of $106.10. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $12.03 billion, a PE ratio of 19.86, a P/E/G ratio of 2.48 and a beta of 0.72.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.07. The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Research analysts forecast that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio is presently 12.38%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on EHC shares. Truist Financial lifted their price objective on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday. Leerink Partners set a $152.00 target price on Encompass Health in a research note on Friday, May 22nd. UBS Group lifted their price target on Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a report on Friday, August 7th. Finally, Weiss Ratings upgraded shares of Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $148.71.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.